| Model Number |
PED2-425-20 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Aneurysm (1708); Nervous System Injury (2689)
|
| Date of Event |
10/08/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Medtronic received a report that at 1 year digital subtraction angiography (dsa) imaging follow-up, the site reported a raymond and roy, occlusion score of class 2.No parent artery stenosis, complete neck coverage, and complete wall apposition.Class 2 was also reported at the 180-day dsa imaging follow up.Previous mrs reported was 0 at the 180 day visit, however at the 1 year visit the site reported a mrs of 2.No known patient symptoms or complications were associatedwith this event.The patient had undergone dense mesh flow diversion implant on (b)(6) 2025 for treatment of a right hemisphere, c7, bifurcation branch aneurysm.Follow-up 1 year dsa imaging reported a previously ruptured, saccular, right hemisphere, c7, bifurcation branch aneurysm with a max diameter of 6.8 mm and a 6.3 mm neck diameter.The landing zone arterial diameter was 4.3 mm distally and 3.7 mm proximally.Dual antiplatelet treatment (dapt) was administered; however, platelet reactivity testing was not performed.
|
| |
|
Additional Manufacturer Narrative
|
|
Based on additional information received, there was no reported device malfunction and the there was no serious patient injury.Mdr decision corrected to not reportable.No additional supplemental reporting is required for this event unless additional information received indicates a reportable event.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information received reported site noted previous entry for mrs2 at 1-year follow-up was incorrect.The patient's mrs at 1-year follow-up has been corrected to 0.Regarding observed r occlusion class 2: the patient had no associated symptoms.No actions taken or planned for observed incomplete occlusion.The event did not result in hospitalization.Based on additional information received, there was no reported device malfunction and the there was no serious patient injury.Mdr decision corrected to not reportable.No additional supplemental reporting is required for this event unless additional information received indicates a reportable event.
|
| |
|
Search Alerts/Recalls
|